
AI in Biotechnology: Global Markets
Description
Report Scope
The report analyzes the trends in the global market for AI in biotechnology. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by product type (software and services), deployment (cloud-based and on-premises), application and end user. Applications consist of drug discovery, clinical trials, diagnostics and others. End users consist of pharmaceutical and biotech companies, academic research institutes, contract R&D organizations (CROs/CDMOs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea and the Rest of Asia-Pacific.
The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that covers such details as financials, product portfolio and recent developments. It analyzes companies’ environmental, social and corporate governance (ESG) initiatives.
Report Includes
Companies Mentioned
Abcellera Biologics Inc.
Absci Corp.
Atomwise Inc.
Benevolentai
Dnanexus Inc.
Eurofins Scientific
Illumina Inc.
Insilico Medicine
Nvidia Corp.
Qiagen
Recursion
Schrodinger Inc.
Sophia Genetics
Tempus Ai Inc.
Xtalpi Inc.
The report analyzes the trends in the global market for AI in biotechnology. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by product type (software and services), deployment (cloud-based and on-premises), application and end user. Applications consist of drug discovery, clinical trials, diagnostics and others. End users consist of pharmaceutical and biotech companies, academic research institutes, contract R&D organizations (CROs/CDMOs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea and the Rest of Asia-Pacific.
The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that covers such details as financials, product portfolio and recent developments. It analyzes companies’ environmental, social and corporate governance (ESG) initiatives.
Report Includes
- 50 data tables and 57 additional tables
- An analysis of the current and future global markets for artificial intelligence (AI) in biotechnology
- Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Estimates of the size of the market and revenue prospects, along with a corresponding market share analysis based on product type, application, deployment type, end user, and region
- Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impact of macroeconomic variables
- Discussion of the underlying opportunities and potential, with the development of novel products, drug discovery, clinical trials and other related applications
- Insights derived from Porter’s Five Forces model and global supply chain analyses
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of the leading companies, including NVIDIA Corp., Tempus AI Inc., Recursion Pharmaceuticals, Schrödinger Inc., and Sophia Genetics
Companies Mentioned
Abcellera Biologics Inc.
Absci Corp.
Atomwise Inc.
Benevolentai
Dnanexus Inc.
Eurofins Scientific
Illumina Inc.
Insilico Medicine
Nvidia Corp.
Qiagen
Recursion
Schrodinger Inc.
Sophia Genetics
Tempus Ai Inc.
Xtalpi Inc.
Table of Contents
142 Pages
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Overview
- Current Market Scenario
- Segmental Analysis
- Regional Market Insights
- Emerging Technologies
- Conclusion
- Chapter 2 Market Overview
- Overview
- Potential Applications of AI in Biotechnology
- Use Cases
- Use Case 1: Drug Discovery
- Use Case 2: Personalized Medicine
- AI's Impact on the Biotech Value Chain
- Macroeconomic Factors Analysis
- Demographic Factors
- Geopolitical Factors
- Impact of U.S. Tariffs
- Porter's Five Forces Analysis
- Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Need for More Effective Drug Discovery and Development Process
- Shift to Personalized Medicine
- Growing Demand for Effective and Early Diagnosis
- Rising Investments in AI in Biopharmaceuticals
- Aging Population and the Growing Prevalence of Chronic Diseases
- Market Restraints
- Data Quality and Bias
- Integration Hurdles
- Ethical Concerns
- Market Opportunities
- AI in Synthetic Biology
- Convergence of AI and Quantum Computing
- Chapter 4 Regulatory Landscape
- Regulatory Scenario
- United States
- Europe
- Asia-Pacific
- Chapter 5 Emerging Technologies and Developments
- Emerging Trends/Technologies
- Key Takeaways
- Agentic AI
- Generative AI
- Federated Learning
- Advanced Neural Networks
- Chapter 6 Market Segmentation Analysis
- Overview
- Segmentation Breakdown
- Market Analysis by Product Type
- Key Takeaways
- Software
- Services
- Market Analysis by Deployment Type
- Key Takeaways
- Cloud-based
- On-premises
- Market Analysis by Application
- Key Takeaways
- Drug Discovery
- Clinical Trials and Optimization
- Diagnostics
- Other Applications
- Market Analysis by End User
- Key Takeaways
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Manufacturing and Development Organizations
- Other End Users
- Geographic Breakdown
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Analysis
- Strategic Initiatives
- Mergers and Acquisitions
- Agreements, Collaborations and Partnerships
- Investment Landscape
- Chapter 8 Sustainability in AI in Biotechnology Market: An ESG Perspective
- Introduction to ESG
- Sustainability Trends and Company Initiatives
- ESG Risk Ratings
- Concluding Remarks
- Chapter 9 Appendix
- Research Methodology
- Sources
- Abbreviations
- Company Profiles
- ABCELLERA BIOLOGICS INC.
- ABSCI CORP.
- ATOMWISE INC.
- BENEVOLENTAI
- DNANEXUS INC.
- EUROFINS SCIENTIFIC
- ILLUMINA INC.
- INSILICO MEDICINE
- NVIDIA CORP.
- QIAGEN
- RECURSION
- SCHRODINGER INC.
- SOPHIA GENETICS
- TEMPUS AI INC.
- XTALPI INC.
- Other Emerging Companies in the Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.